Literature DB >> 32373998

The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.

C Li1, B-H Xu.   

Abstract

Coronavirus Disease-2019 (COVID-19) caused by SARS-CoV-2 infection has rapidly spread all over the world, in just two months. As of 27 March, globally, 509,164 cases confirmed included 23,335 deaths in approximately 150 countries. Recently, WHO has defined COVID-19 as a global pandemic, and considerable researches have focused on the identification and prevention of SARS-CoV-2. As a result, accumulated publications successively reported their early findings, leading to the constant updating of information, which might make confusion for readers. Therefore, this review summarized the current researches about the genomic evolution, variation of SARS-CoV-2, and demonstrated its viral structure for pathogenesis. Meanwhile, we analyzed the epidemiologic and clinical characteristics of COVID-19, in order to provide recommendations for present clinical treatments and inspirations for potential therapy options.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32373998     DOI: 10.26355/eurrev_202004_21044

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.

Authors:  Joseph T Ortega; Maria Luisa Serrano; Beata Jastrzebska
Journal:  Biomolecules       Date:  2020-06-24

2.  Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19.

Authors:  Yoichiro Takahashi; Akira Hayakawa; Rie Sano; Haruki Fukuda; Megumi Harada; Rieko Kubo; Takafumi Okawa; Yoshihiko Kominato
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

3.  Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.

Authors:  Michela Magnano; Riccardo Balestri; Federico Bardazzi; Carlo Mazzatenta; Carlo R Girardelli; Giulia Rech
Journal:  Dermatol Ther       Date:  2020-06-19       Impact factor: 3.858

4.  Individualized prediction nomograms for disease progression in mild COVID-19.

Authors:  Jiaofeng Huang; Aiguo Cheng; Su Lin; Yueyong Zhu; Gongping Chen
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 20.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.